Preimplantation genetic testing for cardiomyopathies: a case series illustrating the clinical and technological perspective
These cases emphasize the importance of selecting patients who will benefit the greatest risk reduction from PGT, reflecting the significance of individual assessment per couple. Additionally, clinicians should be aware and discuss the possibility of PGT with eligible patients consistently to ensure a comprehensive understanding of their reproductive options.
Authors
- Job A.J. Verdonschot (ORCID: https://orcid.org/0000-0001-5549-1298)
- Malou Heijligers (ORCID: https://orcid.org/0000-0002-0174-8278)
- Masoud Zamani Esteki (ORCID: https://orcid.org/0000-0003-3909-0050)
- Aimée Paulussen (ORCID: https://orcid.org/0000-0002-1661-7625)
- Carlijn S. Zietse
- Marianne L. van Buul-van Zwet
- Isa M E Faassen (ORCID: https://orcid.org/0009-0009-4784-6189)
- Nadine H N Weijermans (ORCID: https://orcid.org/0000-0002-2865-3738)
Institutions
- Heidelberg University (DE)
- Maastricht University Medical Centre (NL)
- University Hospital Heidelberg (DE)
- University Medical Center (US)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- ERN GUARD-Heart (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- European Heart Journal - Case Reports
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1093/ehjcr/ytaf630
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00